The technology rally that has dominated US equity markets is showing signs of fatigue as mid-2026 approaches, prompting a strategic shift toward defensive sectors.
According to a report by Handelsblatt, strong quarterly earnings are no longer sufficient to drive tech share prices higher, as investors increasingly focus on the mounting costs associated with artificial intelligence infrastructure.
This dynamic is triggering profit-taking in high-growth tech names and redirecting capital toward healthcare equities, which have lagged behind the broader market in recent quarters.
This rotation aligns with broader market strategist views identifying significant catch-up potential in three underperforming S&P 500 sectors: healthcare, financials, and consumer staples.
As the tech sector faces valuation pressure from elevated AI spending, healthcare stocks are emerging as a primary beneficiary of this sectoral rebalancing.
The shift reflects a growing preference for stability and value among institutional investors who are wary of the diminishing returns on tech-heavy portfolios.